Detalhe da pesquisa
1.
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer.
J Clin Oncol
; 39(21): 2359-2366, 2021 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961488
2.
Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2-negative Metastatic Breast Cancer.
Clin Breast Cancer
; 20(2): 160-167, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980406